Reconsideration of Macrophage and Dendritic Cell Classification

Total Page:16

File Type:pdf, Size:1020Kb

Reconsideration of Macrophage and Dendritic Cell Classification ANTICANCER RESEARCH 32: 2257-2262 (2012) Short Review Reconsideration of Macrophage and Dendritic Cell Classification TAKESHI KADOWAKI1, MISATO SHIMADA1, HIROYUKI INAGAWA1,2,3, CHIE KOHCHI1,2, MITSUOMI HIRASHIMA1 and GEN-ICHIRO SOMA1,3,4 1Faculty of Medicine, Kagawa University, Kagawa, Japan; 2Macrophi Inc., Hayashi-cho, Takamatsu-shi, Kagawa-ken, Japan; 3Institute for Drug Delivery Systems, Tokyo University of Science, Chiba, Japan; 4Institute for Health and Sciences, Tokushima Bunri University, Nishihama, Tokushima, Japan Abstract. It is well known that the activation of innate Macrophages are dynamic and heterogeneous cells that immune cells, especially antigen-presenting cells such as exhibit different roles through their cytokine production and macrophages and dendritic cells, can ameliorate or presentation of microbial components. Currently, monocytes exacerbate various diseases, including cancer. Currently, the and macrophages are divided into several groups: myeloid- macrophages and dendritic cells are categorized into several derived suppressor cells (MDSCs), M1 macrophages groups by their cell surface and intracellular molecules. (classically activated), M2 macrophages (alternatively However, the detailed classification of the differences activated) and regulatory macrophages (Mreg) (1, 2). They between macrophages and dendritic cells has still not been have also been classified on the basis of cell surface markers, established. Here, we summarized and reviewed the previous cytokine production, expression of transcription factors and studies on the classification of macrophages and dendritic their effects on other cells (1-3). cells. In addition, the previous classification of monocytes, It is well known that the differentiation of tumour- macrophages and dendritic cells is discussed based on our associated macrophages (TAMs) and MDSCs are associated findings of macrophage activation, which has both with proteins derived from tumour cells such as macrophage conventional and plasmacytoid dendritic cell phenotype. colony stimulating factor (M-CSF), granulocyte macrophage- colony stimulating factor (GM-CSF) and vascular endothelial Categorization of Monocyte and growth factor (VEGF). These proteins can induce the Macrophage Subsets expansion and accumulation of TAMs and MDSCs in tumour lesions and may also accelerate tumour growth by Macrophages play crucial roles as sentinels in first-line alerts immunosuppressive activities. Some groups have suggested against pathogens and as mediators of host defence. In that these characteristics of TAMs should categorize them as addition, they assist in maintaining homeostasis through M2 macrophages or Mregs (2, 4-6). MDSCs, which express immune regulation, by eliminating foreign substances and the myeloid lineage markers CD11b and Granulocyte- unwanted apoptotic cells. Although macrophages are found differentiation antigen-1 (Gr-1) on their surfaces and include in virtually all tissues, these cells display remarkable granulocyte and monocyte lineage cells, are a heterogeneous plasticity that allow them to efficiently respond to various population of cells that expand during cancer, inflammation environmental signals and change their phenotype. and infection, and that have a remarkable ability to suppress T-cell responses (7-9). Unfortunately, the differences between TAMs and MDSCs are not clear because the detailed definition of what Correspondence to: Gen-Ichiro Soma, Institute for Health Sciences, comprises a TAM is still obscure. Tokushima Bunri University, Nishihama, Yamashiro-cho, Usually, macrophages that are differentiated in vitro due Tokushimashi, 770-8514, Japan. Tel: +81 886028103, Fax: +81 886028103, e-mail: [email protected] to the actions of M-CSF or GM-CSF are designated as either M2 macrophages or M1 macrophages, respectively (10, 11). Key Words: Macrophage, dendritic cell, marker, classification, pDC, In fact, we confirmed that the basal expression levels of review. interleukin (IL)-10 and arginase I mRNA in macrophages 0250-7005/2012 $2.00+.40 2257 ANTICANCER RESEARCH 32: 2257-2262 (2012) Figure 1. Basal cytokines, inducible nitric oxide synthase (iNOS) and arginase (arg I) mRNA expression in macrophages differentiated with macrophage-colony stimulating factor (M-CSF, I) and granulocyte macrophage-colony stimulating factor (GM-CSF, I). Bone marrow derived mononuclear cells were cultured in the presence of M-CSF and GM-CSF for seven days according to previous reports (11, 13) with slight modifications. Total RNA of the cells was extracted and reverse transcripted using a commercial kit. The obtained cDNA was used as template for real-time quantitative PCR. The expression levels of each RNA were normalized to that of β2 microglobulin. Results are means±SEM in tripricate experiments. For statistical comparison, Student’s t-test was performed. *p<0.05, NS: not significant, IL: interleukin, TNF: tumour necrosis factor. that were differentiated with M-CSF were higher than in Categorization of Dendritic Cell Subsets macrophages that were differentiated with GM-CSF in vitro (Figure 1). By comparison, the basal expression level of Dendritic cells (DCs) are well known antigen presenting inflammatory cytokines mRNA such as IL-1β and IL-12, and cells that express MHC class II and CD86. Currently, DCs inducible nitric oxide synthase (iNOS), in macrophages are divided into two main groups: myeloid DCs (mDCs, also differentiated with GM-CSF were higher than those in known as DC-1 or classical DCs cDCs) and plasmacytoid macrophages differentiated with M-CSF. Thus, these results DCs (DC-2, pDCs). mDCs express the cell surface markers suggest that it is reasonable to apply the categorizations of CD11c and do not express B220. In addition, mDCs are also M1 and M2 macrophages in this case. divided into several groups: lymphoid organ resident DCs, When focusing on their cell surface molecule expression, interstitial DCs and monocyte-derived DCs. macrophages that were differentiated with either GM-CSF or Immature mDCs are usually differentiated with GM-CSF M-CSF expressed CD11b and F4/80, which are used as and IL-4 in vitro (14), and these immature DCs are known macrophage markers except for intestinal macrophages (12) to mature after stimulation with agents such as tumor (Figure 2A). In addition, major histocompatibility complex necrosis factor-α (TNF-α), LPS, and other immune class II (MHC class II, I-A/I-E) expression on macrophages stimulators (15, 16). The confirmation of DCs is usually differentiated with GM-CSF was higher than on based on the type of inflammatory cytokines production, macrophages differentiated with M-CSF (Figure 2B). Based such as IL-12, and the expression of cell surface markers, on previous studies, those macrophages differentiated with such as CD80, CD86 and MHC class II molecules. As GM-CSF and M-CSF undoubtedly could be defined as mentioned above, macrophages can also be differentiated macrophages, whereas the macrophages differentiated with with GM-CSF (i.e. categorized as M1 macrophages). In M-CSF expressed Ly-6C, which belongs to Gr-1. In addition, addition, in our experiments, macrophages differentiated Ly-6C expression was up-regulated by lipopolysaccharide with GM-CSF expressed CD11b, F4/80, CD11c and MHC (LPS) and co-culture with tumour cells (13). If M2 class II molecules on their surfaces (Figure 2A and B and macrophages belong to a category that is different from Figure 3). Therefore, it is possible that macrophages MDSCs, then M2 macrophages, such as TAMs, can possibly differentiated with GM-CSF and immature DCs (or DCs) change their phenotype to MDSCs under certain have partly similar characteristics. However, differences physiological conditions. This suggests that the differences between macrophages differentiated with GM-CSF and DCs between TAMs and MDSCs cannot be defined based on their have not been reported previously. This has led us to surface marker expressions. hypothesize that immature DCs (or DCs) are one type of 2258 Kadowaki et al: Classification of Macrophage and Dendritic Cell (Review) were also differentiated with a high concentration of GM- CSF (17). Therefore, it is possible that macrophages differentiated with GM-CSF or immature DCs are easily changed to an MDSC phenotype. It is well known that the surface marker profile that defines pDCs is B220+ CD11c+ or intermediate, Ly-6C+ and plasmacytoid dendritic cell antigen 1+ (PDCA-1+). Immature pDCs also express toll like receptor (TLR)7 or TLR9 and produce type I interferons (IFNs), such as IFN-α and IFN- β, via myeloid differentiation factor 88 (MyD88) and interferon regulatory factor (IRF) 7 signalling cascade (18, 19). The functional roles of type I IFNs are the activation of CD8+ T- and natural killer (NK) cells and the induction of Th1 response (20-22). In contrast, mature pDCs reduce production of type I IFNs, which also leads to immune tolerogenic activity, such as inducing the production of IL- 10 by CD8+ T-cells and Tregs, or inducing Th2 responses (23). Therefore, pDCs play crucial roles linking the innate and adaptive arms of the immune system. Recently, many investigators have reported the frequency of pDCs in various diseases. Although pDCs classically belong to the lymphoid lineage, they are currently defined as a subset of DCs derived from both myeloid and lymphoid precursors (24). We also confirmed the frequency of pDCs in tumour-bearing mice. CD11c+ PDCA-1+ cells infiltrated into Figure 2. Flow cytometry analyses of macrophages differentiated
Recommended publications
  • Regulation of Macrophage Development and Function in Peripheral Tissues
    REVIEWS Regulation of macrophage development and function in peripheral tissues Yonit Lavin, Arthur Mortha, Adeeb Rahman and Miriam Merad Abstract | Macrophages are immune cells of haematopoietic origin that provide crucial innate immune defence and have tissue-specific functions in the regulation and maintenance of organ homeostasis. Recent studies of macrophage ontogeny, as well as transcriptional and epigenetic identity, have started to reveal the decisive role of the tissue stroma in the regulation of macrophage function. These findings suggest that most macrophages seed the tissues during embryonic development and functionally specialize in response to cytokines and metabolites that are released by the stroma and drive the expression of unique transcription factors. In this Review, we discuss how recent insights into macrophage ontogeny and macrophage–stroma interactions contribute to our understanding of the crosstalk that shapes macrophage function and the maintenance of organ integrity. Mononuclear phagocyte Macrophages are key components of the innate immune characterized the transcriptional and epigenetic pro- system system that reside in tissues, where they function as grammes of tissue-resident macrophages and revealed (MPS). A group of bone immune sentinels. They are uniquely equipped to sense the extent of diversity in these populations1,8. In addi- marrow-derived cells and respond to tissue invasion by infectious microorgan- tion to differences in ontogeny, locally derived tissue (monocytes, macrophages and isms and tissue
    [Show full text]
  • The Distribution of Immune Cells in the Uveal Tract of the Normal Eye
    THE DISTRIBUTION OF IMMUNE CELLS IN THE UVEAL TRACT OF THE NORMAL EYE PAUL G. McMENAMIN Perth, Western Australia SUMMARY function of these cells in the normal iris, ciliary body Inflammatory and immune-mediated diseases of the and choroid. The role of such cell types in ocular eye are not purely the consequence of infiltrating inflammation, which will be discussed by other inflammatory cells but may be initiated or propagated authors in this issue, is not the major focus of this by immune cells which are resident or trafficking review; however, a few issues will be briefly through the normal eye. The uveal tract in particular considered where appropriate. is the major site of many such cells, including resident tissue macro phages, dendritic cells and mast cells. This MACRO PHAGES review considers the distribution and location of these and other cells in the iris, ciliary body and choroid in Mononuclear phagocytes arise from bone marrow the normal eye. The uveal tract contains rich networks precursors and after a brief journey in the blood as of both resident macrophages and MHe class 11+ monocytes immigrate into tissues to become macro­ dendritic cells. The latter appear strategically located to phages. In their mature form they are widely act as sentinels for capturing and sampling blood-borne distributed throughout the body. Macrophages are and intraocular antigens. Large numbers of mast cells professional phagocytes and play a pivotal role as are present in the choroid of most species but are effector cells in cell-mediated immunity and inflam­ virtually absent from the anterior uvea in many mation.1 In addition, due to their active secretion of a laboratory animals; however, the human iris does range of important biologically active molecules such contain mast cells.
    [Show full text]
  • Development of Plasmacytoid and Conventional Dendritic Cell Subtypes from Single Precursor Cells Derived in Vitro and in Vivo
    ARTICLES Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo Shalin H Naik1,2, Priyanka Sathe1,3, Hae-Young Park1,4, Donald Metcalf1, Anna I Proietto1,3, Aleksander Dakic1, Sebastian Carotta1, Meredith O’Keeffe1,4, Melanie Bahlo1, Anthony Papenfuss1, Jong-Young Kwak1,4,LiWu1 & Ken Shortman1 The development of functionally specialized subtypes of dendritic cells (DCs) can be modeled through the culture of bone marrow with the ligand for the cytokine receptor Flt3. Such cultures produce DCs resembling spleen plasmacytoid DCs (pDCs), http://www.nature.com/natureimmunology CD8+ conventional DCs (cDCs) and CD8– cDCs. Here we isolated two sequential DC-committed precursor cells from such cultures: dividing ‘pro-DCs’, which gave rise to transitional ‘pre-DCs’ en route to differentiating into the three distinct DC subtypes (pDCs, CD8+ cDCs and CD8– cDCs). We also isolated an in vivo equivalent of the DC-committed pro-DC precursor cell, which also gave rise to the three DC subtypes. Clonal analysis of the progeny of individual pro-DC precursors demonstrated that some pro-DC precursors gave rise to all three DC subtypes, some produced cDCs but not pDCs, and some were fully committed to a single DC subtype. Thus, commitment to particular DC subtypes begins mainly at this pro-DC stage. Dendritic cells (DCs) are antigen-presenting cells crucial for the innate macrophages12. Further ‘downstream’, ‘immediate’ precursors have and adaptive response to infection as well as for maintaining immune been identified for several DC types, including Ly6Chi monocytes as 3,4,6 13 Nature Publishing Group Group Nature Publishing tolerance to self tissue.
    [Show full text]
  • The Biochemical and Biophysical Mechanisms of Macrophage Migration
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2015 The Biochemical and Biophysical Mechanisms of Macrophage Migration Laurel Erin Hind University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Allergy and Immunology Commons, Biomedical Commons, Immunology and Infectious Disease Commons, and the Medical Immunology Commons Recommended Citation Hind, Laurel Erin, "The Biochemical and Biophysical Mechanisms of Macrophage Migration" (2015). Publicly Accessible Penn Dissertations. 1062. https://repository.upenn.edu/edissertations/1062 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1062 For more information, please contact [email protected]. The Biochemical and Biophysical Mechanisms of Macrophage Migration Abstract The ability of macrophages to migrate is critical for a proper immune response. During an innate immune response, macrophages migrate to sites of infection or inflammation where they clear pathogens through phagocytosis and activate an adaptive immune response by releasing cytokines and acting as antigen- presenting cells. Unfortunately, improper regulation of macrophage migration is associated with a variety of dieases including cancer, atherosclerosis, wound-healing, and rheumatoid arthritis. In this thesis, engineered substrates were used to study the chemical and physical mechanisms of macrophage migration. We first used microcontact printing to generate surfaces
    [Show full text]
  • "Macrophage Function Disorders". In: Encyclopedia of Life Sciences (ELS)
    Macrophage Function Advanced article Disorders Article Contents . Introduction Keith M Lee, McMaster Immunology Research Centre & M. G. DeGroote Institute for . Macrophage Functions . Macrophage Phenotypic Diversity Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada . Role in Disease Charles Yin, McMaster Immunology Research Centre & M. G. DeGroote Institute for Infectious . Primary Immunodeficiencies in Macrophage Function Disease Research, McMaster University, Hamilton, Ontario, Canada . Concluding Remarks Chris P Verschoor, McMaster Immunology Research Centre & M. G. DeGroote Institute for Online posting date: 20th September 2013 Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada Dawn ME Bowdish, McMaster Immunology Research Centre & M. G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada Based in part on the previous version of this eLS article ‘Macrophage Function Disorders’ (2009) by Dawn ME Bowdish and Siamon Gordon. Macrophages are sentinel cells of the innate immune tissue microenvironment and can change considerably response. Macrophages recognise pathogen-associated with exposure to infectious and antigenic agents. They are molecular patterns (e.g. microbial products) and endo- relatively long-lived, biosynthetically active cells and genous ligands (e.g. apoptotic cells) through a broad and express diverse surface receptors and secretory products. They adapt readily to changes in their milieu and help to adaptable range of pattern-recognition receptors. The maintain homoeostasis locally and systemically. If unable consequence of this recognition is generally effective to deal adequately with an infectious or injurious stimulus, clearance via phagocytosis; however, when this is not macrophages initiate a chronic inflammatory process, effective, macrophages may become inappropriately which can contribute to persistent tissue damage; they can activated and initiate an inappropriate inflammatory also mediate acute, sometimes massive, responses from response.
    [Show full text]
  • The Importance of Dendritic Cells in Maintaining Immune Tolerance Cindy Audiger, M
    The Importance of Dendritic Cells in Maintaining Immune Tolerance Cindy Audiger, M. Jubayer Rahman, Tae Jin Yun, Kristin V. Tarbell and Sylvie Lesage This information is current as of October 1, 2021. J Immunol 2017; 198:2223-2231; ; doi: 10.4049/jimmunol.1601629 http://www.jimmunol.org/content/198/6/2223 Downloaded from References This article cites 166 articles, 73 of which you can access for free at: http://www.jimmunol.org/content/198/6/2223.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 1, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Th eJournal of Brief Reviews Immunology The Importance of Dendritic Cells in Maintaining Immune Tolerance x { Cindy Audiger,*,†,1 M. Jubayer Rahman,‡,1 Tae Jin Yun, , Kristin V. Tarbell,‡ and Sylvie Lesage*,† Immune tolerance is necessary to prevent the immune specific depletion of CD11c+ cells (3).
    [Show full text]
  • Understanding the Immune System: How It Works
    Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute NIH Publication No. 03-5423 September 2003 www.niaid.nih.gov www.nci.nih.gov Contents 1 Introduction 2 Self and Nonself 3 The Structure of the Immune System 7 Immune Cells and Their Products 19 Mounting an Immune Response 24 Immunity: Natural and Acquired 28 Disorders of the Immune System 34 Immunology and Transplants 36 Immunity and Cancer 39 The Immune System and the Nervous System 40 Frontiers in Immunology 45 Summary 47 Glossary Introduction he immune system is a network of Tcells, tissues*, and organs that work together to defend the body against attacks by “foreign” invaders. These are primarily microbes (germs)—tiny, infection-causing Bacteria: organisms such as bacteria, viruses, streptococci parasites, and fungi. Because the human body provides an ideal environment for many microbes, they try to break in. It is the immune system’s job to keep them out or, failing that, to seek out and destroy them. Virus: When the immune system hits the wrong herpes virus target or is crippled, however, it can unleash a torrent of diseases, including allergy, arthritis, or AIDS. The immune system is amazingly complex. It can recognize and remember millions of Parasite: different enemies, and it can produce schistosome secretions and cells to match up with and wipe out each one of them.
    [Show full text]
  • Infections Macrophage Polarization in Bacterial
    Macrophage Polarization in Bacterial Infections Marie Benoit, Benoît Desnues and Jean-Louis Mege This information is current as J Immunol 2008; 181:3733-3739; ; of September 24, 2021. doi: 10.4049/jimmunol.181.6.3733 http://www.jimmunol.org/content/181/6/3733 Downloaded from References This article cites 68 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/181/6/3733.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 24, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Macrophage Polarization in Bacterial Infections Marie Benoit, Benoît Desnues, and Jean-Louis Mege1 Converging studies have shown that M1 and M2 mac- tokines and microbial products (2). More recently, M2 macro- rophages are functionally polarized in response to mi- phages have been characterized by functional expression of al- croorganisms and host mediators. Gene expression ternative activation markers.
    [Show full text]
  • Immunology 101
    Immunology 101 Justin Kline, M.D. Assistant Professor of Medicine Section of Hematology/Oncology Committee on Immunology University of Chicago Medicine Disclosures • I served as a consultant on Advisory Boards for Merck and Seattle Genetics. • I will discuss non-FDA-approved therapies for cancer 2 Outline • Innate and adaptive immune systems – brief intro • How immune responses against cancer are generated • Cancer antigens in the era of cancer exome sequencing • Dendritic cells • T cells • Cancer immune evasion • Cancer immunotherapies – brief intro 3 The immune system • Evolved to provide protection against invasive pathogens • Consists of a variety of cells and proteins whose purpose is to generate immune responses against micro-organisms • The immune system is “educated” to attack foreign invaders, but at the same time, leave healthy, self-tissues unharmed • The immune system can sometimes recognize and kill cancer cells • 2 main branches • Innate immune system – Initial responders • Adaptive immune system – Tailored attack 4 The immune system – a division of labor Innate immune system • Initial recognition of non-self (i.e. infection, cancer) • Comprised of cells (granulocytes, monocytes, dendritic cells and NK cells) and proteins (complement) • Recognizes non-self via receptors that “see” microbial structures (cell wall components, DNA, RNA) • Pattern recognition receptors (PRRs) • Necessary for priming adaptive immune responses 5 The immune system – a division of labor Adaptive immune system • Provides nearly unlimited diversity of receptors to protect the host from infection • B cells and T cells • Have unique receptors generated during development • B cells produce antibodies which help fight infection • T cells patrol for infected or cancerous cells • Recognize “foreign” or abnormal proteins on the cell surface • 100,000,000 unique T cells are present in all of us • Retains “memory” against infections and in some cases, cancer.
    [Show full text]
  • Granulocytes, Macrophages, and Dendritic Cells Arise from A
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 3038-3042, April 1993 Immunology Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow KAYO INABA*t, MUNEO INABA*, MASASHI DEGUCHI*, KATSUHIKO HAGI*, RYoJi YASUMIZUf, SUSUMU IKEHARAt, SHIGERU MURAMATSU*, AND RALPH M. STEINMAN§ *Department of Zoology, Faculty of Science, Kyoto University, Sakyo, Kyoto 606, Japan; tFirst Department of Pathology, Kansai Medical University, Moriguchi, Osaka 570, Japan; and §Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, NY 10021 Communicated by Zanvil A. Cohn, December 21, 1992 ABSTRACT The developmental origin of dendritic cells, a lineage-restricted macrophage and granulocyte colony- specialized system ofmajor histocompatibility complex (MHC) stimulating factors (M-CSF and G-CSF, respectively) (8, 10, class 11-rich antigen-presenting cells for T-celi immunity and 12). tolerance, is not well characterized. Granulocyte-macrophage Since GM-CSF can induce the formation of mixed popu- colony-stimulating factor (GM-CSF) is known to stimulate lations ofgranulocytes and macrophages in semi-solid colony dendritic cells, including growth and development from MHC systems (15), we asked whether dendritic cells could also class 11-negative precursors in suspension cultures of mouse arise from a colony-forming precursor that is common to bone marrow. Here we studied colony formation in semi-solid phagocytes. Cells with some of the features of dendritic cells methylcellulose cultures, a classical bioassay system in which have been detected in human cell colonies that were induced GM-CSF induces the formation of mixed granulocyte- with lectin-conditioned medium (16) and more recently with macrophage colonies.
    [Show full text]
  • Ornithine Decarboxylase Regulates M1 Macrophage Activation And
    Ornithine decarboxylase regulates M1 macrophage PNAS PLUS activation and mucosal inflammation via histone modifications Dana M. Hardbowera,b, Mohammad Asimb, Paula B. Luisc, Kshipra Singhb, Daniel P. Barryb, Chunying Yangd,e, Meredith A. Steevese, John L. Clevelandd,e, Claus Schneiderc, M. Blanca Piazuelob, Alain P. Gobertb, and Keith T. Wilsona,b,f,g,h,1 aDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232; bDivision of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232; cDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232; dDepartment of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, FL 33612; eDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458; fDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; gCenter for Mucosal Inflammation and Cancer, Vanderbilt University Medical Center, Nashville, TN 37232; and hVeterans Affairs Tennessee Valley Healthcare System, Nashville, TN 37232 Edited by Carl F. Nathan, Weill Medical College of Cornell University, New York, NY, and approved December 20, 2016 (received for review September 6, 2016) Macrophage activation is a critical step in host responses during pathogens is macrophage activation. Macrophages have the ca- bacterial infections. Ornithine decarboxylase (ODC), the rate-limiting pacity to alter cytokine/chemokine production and various other enzyme in polyamine metabolism, has been well studied in epithelial functions along the spectrum of M1 or M2 activation based on the cells and is known to have essential roles in many different cellular stimulus detected (12–14). M1 macrophages represent a highly functions. However, its role in regulating macrophage function during proinflammatory and antimicrobial subset of macrophages (12–14).
    [Show full text]
  • Cd47-Sirpα Interaction and IL-10 Constrain Inflammation-Induced Macrophage Phagocytosis of Healthy Self-Cells
    Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells Zhen Biana,b, Lei Shia, Ya-Lan Guoa, Zhiyuan Lva, Cong Tanga, Shuo Niua, Alexandra Tremblaya, Mahathi Venkataramania, Courtney Culpeppera, Limin Lib, Zhen Zhoub, Ahmed Mansoura, Yongliang Zhangc, Andrew Gewirtzd, Koby Kiddera,e, Ke Zenb, and Yuan Liua,d,1 aProgram of Immunology and Cell Biology, Department of Biology, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30302; bState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University, Nanjing, Jiangsu 210093, China; cDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, Life Science Institute (LSI) Immunology Programme, National University of Singapore, Singapore 117456; dCenter for Inflammation, Immunity and Infection, Georgia State University, Atlanta, GA 30303; and eDepartment of Cell Biology, Rutgers University, New Brunswick, NJ 08901 Edited by Jason G. Cyster, University of California, San Francisco, CA, and approved July 11, 2016 (received for review October 28, 2015) − − Rapid clearance of adoptively transferred Cd47-null (Cd47 / ) cells in The CD47-SIRPα mechanism was first reported by Oldenborg congeneic WT mice suggests a critical self-recognition mechanism, et al. (1), who had demonstrated in red blood cell (RBC) in which CD47 is the ubiquitous marker of self, and its interaction transfusion experiments that WT mice rapidly eliminate syngeneic − with macrophage signal regulatory protein α (SIRPα) triggers inhib- Cd47-null (Cd47 ) RBCs through erythrophagocytosis in the itory signaling through SIRPα cytoplasmic immunoreceptor tyrosine- spleen and that the lack of tyrosine phosphorylation in SIRPα based inhibition motifs and tyrosine phosphatase SHP-1/2.
    [Show full text]